A French Technology Transfer Office offers a new adujvant which improves therapeutic vaccination

Summary:

A French Technology Transfer Office (TTO) offers a new adjuvant which improves therapeutic vaccination and more precisely the vaccines' immune response thanks to a patented micro-particle containing a new liposome.

The French TTO is looking for interested pharmacology corporates or biotechnology SMEs, either for a licensing agreement or a technical cooperation agreement.

Reference: TOFR20180315001

Country: France

Submitted: 19. 8. 2019

View Partnering Opportunity

Keywords

Technology: Human vaccines; Pharmaceutical Products / Drugs; Cellular and Molecular Biology; Protein Engineering; Microbiology

Market: Cellular and Molecular Biology; Microbiology; Therapeutic services; Gynaecology; Anatomy, Pathology, Immunology, Physiology;

NACE: Research and experimental development on biotechnology

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.